Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.
about
Prospects and pitfalls of personalizing therapies for sarcomas: from children, adolescents, and young adults to the elderlyPotential Mechanisms underlying the Protective Effect of Pregnancy against Breast Cancer: A Focus on the IGF PathwayInteractions between vitamin D and IGF-I: from physiology to clinical practice.Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition.Peptide receptor targeting in cancer: the somatostatin paradigm.Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model.Somatostatin receptors in non-neuroendocrine malignancies: the potential role of somatostatin analogs in solid tumors.Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.Does pasireotide directly modulate skeletal muscle metabolism?Editorial: How Reproductive History Influences Our Breast Cancer Risk.
P2860
Q27025344-7B65DA6C-4839-4D3F-9770-C4CF475BC50EQ28069539-1F91DD07-CD2B-4F87-BDA5-1942B6606757Q34352477-7FE4A7B4-8AED-477B-A84A-2BD9D9AB8C78Q35000609-663E0F59-BAAC-4C16-9D64-11E28083E5A7Q36368070-E036AEA6-5766-41F2-97EF-28307C17DAD3Q36638046-D327FE8E-961B-4F5E-9341-796FD4D9AAFEQ37066453-6FC20837-6A4B-4FC9-B014-2F59F8AEF5EFQ37898112-9AD14573-999D-41A5-B4AA-0BCA26E9DA34Q37963505-B41B2EE7-93FD-458E-87B4-605544F715FBQ48307756-800EB127-0129-42B6-A3C0-18069B9815C3Q49213022-268932DC-AFB2-434B-8ADC-00BC12F7FCE2
P2860
Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@en
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@nl
type
label
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@en
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@nl
prefLabel
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@en
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@nl
P2093
P2860
P1433
P1476
Pasireotide, an IGF-I action i ...... l-induced mammary hyperplasia.
@en
P2093
Baljit Singh
David L Kleinberg
Pietro Ameri
P2860
P2888
P356
10.1007/S11102-010-0257-0
P577
2011-03-01T00:00:00Z